NLR advances cell-free biomanufacturing to make chemicals from biomass

A nearly $70 billion U.S. biofuels economy now runs on two main technology platforms, and National Laboratory of the Rockies on March 26 outlined a third: enzyme-only biomanufacturing. Biochemical technologies already make about 17 billion gallons of ethanol a year, while NLR’s biomass program has been issuing biotechnology patents since the 1980s. The new route strips away the cell and keeps the reaction chemistry.

Two toolboxes already run the market

The current biomass economy rests on two established platforms. Biochemical technologies use microorganisms to convert plant biomass sugars into alcohols, other biofuels or chemicals, while chemical technologies use catalysts to turn biomass and wastes into similar target products. Cell-free biomanufacturing fits as a different way to push carbon from biomass into higher-value molecules, not as a replacement for all industrial biology.

Its biomass program, founded in the 1980s, has helped develop new capabilities, products and efficiencies for the industry. NLR counts more than 294 biotechnology patents issued since 2020.

What changes when cells come out

Cell-free biomanufacturing uses enzymes without cells to convert biomass-derived feedstocks into chemicals. In NLR’s model, there are no cells, organelles or DNA, only a handpicked lineup of enzymes driving controlled and precise reaction chains. That gives process designers a way to focus on the chemistry they want and leave out much of the biology they do not.

Enzymes outside living organisms are less constrained by product toxicity, feedstock toxicity, transport limits, complex metabolism and competing pathways. In whole-cell fermentation, those constraints can force carbon into byproducts, slow conversion or complicate scale-up. In a cell-free system, the reaction network can be assembled more deliberately, which is why the approach is drawing interest as a route to tighter selectivity and more direct product formation from biomass sugars and other feedstocks.

Yannick Bomble, NLR’s principal scientist and R&D leader in cell-free biomanufacturing, sits at the center of that effort. The work is relevant not just to bioenergy, but also to pharma and fine chemicals, where precise reaction control and product selectivity can matter as much as throughput. The same logic applies to ethanol-linked biomanufacturing: if a carbon stream can be routed through fewer biological detours, the plant has a better chance of turning sugar into a targeted chemical rather than a mixed broth that needs more cleanup.

Why the field is broadening beyond fuels

The wider literature now treats cell-free systems as a platform technology, not a niche lab trick. A 2021 OSTI review identified cell-free biomanufacturing as a platform for protein therapeutics, vaccines, enzyme biocatalysts, fuels and commodity chemicals. Another 2021 review on cell-free synthetic biology outlined biomolecular reactions outside cells for drug discovery, metabolic engineering, biomanufacturing, diagnostics and education.

For biomass processors, that breadth widens the list of output streams that can be made from the same feedstock logic. A plant that already handles sugars, intermediates or lignocellulosic-derived molecules can, in principle, look beyond fuel gallons and toward chemicals with higher per-unit value. Cell-free systems can be tuned for a target molecule in a way that whole cells, with their own survival rules and competing pathways, often cannot.

Where the technology can improve process economics

A 2020 review on cell-free synthetic biochemistry found the approach can deliver higher yield, better regioselectivity, fewer reaction steps and lower operating temperatures. Fewer steps can reduce purification burden, while lower temperatures can cut energy demand and ease material constraints in some systems.

The same review also flagged scale-up and cofactor cost and reuse as major hurdles. Enzymes still need to be supplied, managed and kept productive, and many reaction cascades depend on expensive cofactors that must be regenerated efficiently. That is the line between a promising pathway on paper and a plant that can compete with established fermentation or petrochemical routes on cost.

The DOE backdrop still sets the ambition

A Science review on the path forward for biofuels and biomaterials cited long-running U.S. Department of Energy goals to replace 30% of liquid petroleum transportation fuel with biofuels and 25% of industrial organic chemicals with biomass-derived chemicals by 2025. Those targets keep cell-free biomanufacturing in view even as conventional fermentation remains the main workhorse in ethanol. The technology offers another way to reach biomass-derived liquids and chemicals without asking living cells to solve every conversion problem.